On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

According to state law, no PBM can pay a pharmacy below their cost to purchase a drug and below a fair and reasonable rate on top of that. However, pharmacists testified to lawmakers in a Thursday ...

UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...

The Federal Trade Commission sued on Friday the three largest pharmaceutical intermediaries charged with negotiating drug ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...